Alnylam Pharmaceuticals, Inc.

BNP Paribas Asset Management Holding S.A. ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

109,604

Value ($000)

43,590

Weight

0.0%

2013 Q4 - 2025 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	43,590	0.0%	109,604	12/31/2025
2025 Q3	11/7/2025	14,756	0.0%	32,369	9/30/2025
2025 Q2	8/6/2025	10,232	0.0%	31,402	6/30/2025
2014 Q1	5/13/2014	9,330	0.1%	138,960	3/31/2014
2013 Q4	2/14/2014	6,254	0.0%	97,222	12/31/2013